HUGONNET , Florent

Last name: HUGONNET

First name: Florent

2022 (v1)

Publication

Metadata-only

Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer

Humbert, Olivier Bauckneht, Matteo Gal, Jocelyn

Purpose We evaluated the prognostic value of immunotherapy-induced organ inflammation observed on (18)FDG PET in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICPIs). Methods Data from patients with IIIB/IV NSCLC included in two different prospective trials were analyzed. (18)FDG PET/CT exams were...

Uploaded on: January 31, 2024
April 22, 2024 (v1)

Journal article

Metadata-only

Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy

Tricarico, Pierre Chardin, David Martin, Nicolas

Purpose Because of atypical response imaging patterns in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICPIs), new biomarkers are needed for a better monitoring of treatment efficacy. The aim of this prospective study was to evaluate the prognostic value of volume-derived...

Uploaded on: January 13, 2025
September 2022 (v1)

Journal article

Metadata-only

Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer

Humbert, Olivier Bauckneht, Matteo Gal, Jocelyn

Abstract Purpose We evaluated the prognostic value of immunotherapy-induced organ inflammation observed on 18 FDG PET in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICPIs). Methods Data from patients with IIIB/IV NSCLC included in two different prospective trials were analyzed. 18 FDG PET/CT exams...

Uploaded on: December 4, 2022

HUGONNET , Florent

Recent uploads